SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-105410
Filing Date
2009-05-08
Accepted
2009-05-08 16:19:14
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 ALLERGAN, INC. FORM 10-Q d10q.htm 10-Q 875547
2 FIRST AMENDMENT TO LICENSE, DEVELOPMENT, SUPPLY AND DISTRIBUTION AGREEMENT dex1062.htm EX-10.62 16614
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 8010
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8167
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER & PRINCIPAL FINANCIAL OFFICER dex32.htm EX-32 7873
  Complete submission text file 0001193125-09-105410.txt   917576
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 09811039
SIC: 2834 Pharmaceutical Preparations